📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
41%
🔄 Reverse Split
45%
• 50-day avg $1.47 approaching $1 threshold
• Only 6 months cash — financial pressure
📉 Score Deterioration
40%
• Score rose 26 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 6 months remaining
💹 Market Data
Market Cap$1.74M
Shares Outstanding938.9K
FloatN/A
Cash$19.5K
Debt$80.0K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest3.2K
Days to Cover1.0
% of FloatN/A
FINRA data as of Dec 15, 2025
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for GRNL
📊 GRNL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GRNL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.